5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene
- PMID: 9708520
5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene
Abstract
The planning and individualization of gene therapy with suicide genes such as herpes simplex virus thymidine kinase (HSV-tk) necessitates the assessment of the enzyme activity expressed in the tumor. This can be done by uptake measurements of specific substrates for HSV-tk. Due to the molecular structure of 5-fluoro-1-(2'-deoxy-fluoro-beta-D-ribofuranosyl)uracil (FFUdR), it may be a substrate for both the mammalian thymidine kinase and HSV-tk.
Methods: Using a HSV-tk-expressing rat hepatoma cell line and a control cell line (bearing the empty vector) the uptake of 3H-FFUdR was determined with increasing incubation periods. Furthermore, measurements with graded mixtures of HSV-tk-expressing cells and control cells were made. To elucidate the mechanism of FFUdR transport into cells, a series of inhibition/competition experiments was performed with challenge inhibitors of the nucleoside and the nucleobase transport systems.
Results: The uptake studies with tritiated FFUdR revealed a 14- to 19-fold higher accumulation in the HSV-tk-expressing cell line compared to the control cell line. While the 3H-FFUdR uptake was 3- to 4-fold higher than the 3H-ganciclovir uptake in the HSV-tk-expressing cells, it was also higher in control cells (5-fold). Furthermore, FFUdR accumulation was linearly correlated with the amount of HSV-tk-expressing cells. FFUdR uptake and growth inhibition by therapeutic doses of ganciclovir were highly correlated, with r = 0.96. Inhibition/competition experiments showed that FFUdR is transported mainly by the equilibrative and the concentrative nucleoside transporter but not by the nucleobase transport systems.
Conclusion: The FFUdR uptake is an indicator of the HSV-tk activity in tumor cells and can be used as a prognostic marker during gene therapy with HSV-tk. The relative merits of ganciclovir and FFUdR as specific substrates for HSV-tk will need to be further explored in vivo.
Similar articles
-
Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.Eur J Nucl Med. 2001 Nov;28(11):1690-6. doi: 10.1007/s002590100644. Eur J Nucl Med. 2001. PMID: 11702112
-
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.J Nucl Med. 2006 Jul;47(7):1161-71. J Nucl Med. 2006. PMID: 16818951
-
Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.J Nucl Med. 1997 Feb;38(2):287-94. J Nucl Med. 1997. PMID: 9025757
-
Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.Q J Nucl Med. 1999 Jun;43(2):163-9. Q J Nucl Med. 1999. PMID: 10429512 Review.
-
Thymidine kinase gene transfer by herpes simplex virus.Bull Cancer. 1976 Jul-Sep;63(3):393-8. Bull Cancer. 1976. PMID: 187268 Review.
Cited by
-
Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.J Nucl Med. 2009 May;50(5):757-64. doi: 10.2967/jnumed.108.058438. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372484 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical